Table 5.
Outcomes of sensitivity analysis.
| Main source of heterogeneity | SMD (95% CI) | I 2 |
|---|---|---|
| Total opioid consumption (PENG block vs SFIB) | *−8.25 (−16.48 to −0.02) | 68% |
| Vamshi et al. (11) | −4.3 (−10.99 to 2.39) | 32% |
| 6 h static pain score (PENG block vs SFIB) | −0.30 (−0.74 to 0.15) | 55% |
| Choi et al. (29) | −0.09 (−0.42 to 0.24) | 0% |
| 3 h static pain score (PENG block vs PAI) | 0.17 (−0.31 to 0.66) | 69% |
| Et et al. (12) | 0.43 (0.10–0.75) | 0% |
| 6 h static pain score (PENG block vs PAI) | 0.38 (−0.25 to 1.01) | 86% |
| Et et al. (12) | 0.71 (0.41–1.01) | 20% |
| 12 h static pain score (PENG block vs PAI) | 0.41 (0.08–0.75) | 51% |
| Iglesias et al. (30) | 0.5 (0.14–0.86) | 49% |
| Ye et al. (13) | 0.28 (−0.01 to 0.57) | 10% |
| 24 h static pain score (PENG block vs PAI) | 0.23 (−0.10 to 0.57) | 51% |
| Bravo et al. (27) | 0.07 (−0.18 to 0.33) | 0% |
| 12 h dynamic pain score (PENG block vs PAI) | 0.73 (−0.50 to 1.96) | 94% |
| Ye et al. (13) | 0.11 (−0.26 to 0.49) | 6% |
PAI, the periarticular anesthetic infiltration; PENG, the pericapsular nerve group block; SFIB, the suprainguinal fascia iliaca block; SMD, standardized mean difference.
Value is mean difference (95% CI).
This work is licensed under a